High cost of enoxaparin sodium offset by reduced hospital readmissions

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1272, 2001-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enoxaparin sodium cost effective for VTE prophylaxis

By  

Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Enoxaparin sodium cost effective for VTE prophylaxis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 507, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Fondaparinux Sodium Compared with Enoxaparin Sodium: A Cost-Effectiveness Analysis

By Afsane Bjorvatn   Frode Kristiansen  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 2, 2005-01 ,pp. : 121-130

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin for Acute Coronary Syndromes: A Canadian Hospital Perspective

By Balen R.M.  

PharmacoEconomics, Vol. 16, Iss. 5, 1999-11 ,pp. : 533-542

Adis International

Access to resources Recommend Favorite

A Cost-Effectiveness Analysis of Fondaparinux Sodium Compared with Enoxaparin Sodium as Prophylaxis Against Venous Thromboembolism: Use in Patients Undergoing Major Orthopaedic Surgery

By Sullivan S.D.  

PharmacoEconomics, Vol. 22, Iss. 9, 2004-01 ,pp. : 605-620

Adis International

Access to resources Recommend Favorite